Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis

Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remain...

Full description

Saved in:
Bibliographic Details
Main Authors: Ce Chen, Jialin Wang, Mengqin Cheng, Haifeng Xie, Wei Li, Chaofeng Zhang
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S104366182500012X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199562594189312
author Ce Chen
Jialin Wang
Mengqin Cheng
Haifeng Xie
Wei Li
Chaofeng Zhang
author_facet Ce Chen
Jialin Wang
Mengqin Cheng
Haifeng Xie
Wei Li
Chaofeng Zhang
author_sort Ce Chen
collection DOAJ
description Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remains unclear. Our study revealed HB's beneficial effects in alleviating PF symptoms and restoring the intestinal mucosal barrier. Subsequently, the microbiota-dependent antifibrotic efficacy of HB was verified using various delivery routes, antibiotic treatments, and faecal microbiota transplantation. Functionally, 16S rRNA sequencing, untargeted metabolomics, and co-incubation experiments revealed that the antifibrotic efficacy of HB was primarily contingent on the enrichment of Muribaculum intestinale and its metabolite, 3-hydroxybutyric acid. Mechanistically, indoleamine 2,3- dioxygenase 1 (IDO1)-mediated ferroptosis was identified as a pivotal process in initiating PF, and the anti-fibrotic efficacy of HB relies on suppressing IDO1-mediated ferroptosis. Conversely, IDO1 deficiency alleviated the symptoms of bleomycin-induced PF and ferroptosis in mice. Coincidentally, both IDO1 overexpression and ferroptosis were observed in the pulmonary tissue of patients with idiopathic PF. Collectively, this study revealed that HB alleviates PF by eliminating intestinal microecology and metabolism and highlights the feasibility of targeting IDO1 for PF treatment.
format Article
id doaj-art-3f0d95d6bfee47de8dc24a3f17e1bc10
institution Kabale University
issn 1096-1186
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-3f0d95d6bfee47de8dc24a3f17e1bc102025-02-08T04:59:41ZengElsevierPharmacological Research1096-11862025-02-01212107587Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosisCe Chen0Jialin Wang1Mengqin Cheng2Haifeng Xie3Wei Li4Chaofeng Zhang5Sino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaSino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaSino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaResearch and Development Department, Chengdu Biopurify Phytochemicals Ltd., Chengdu, ChinaFaculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan; Corresponding authors.Sino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, China; Corresponding authors.Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remains unclear. Our study revealed HB's beneficial effects in alleviating PF symptoms and restoring the intestinal mucosal barrier. Subsequently, the microbiota-dependent antifibrotic efficacy of HB was verified using various delivery routes, antibiotic treatments, and faecal microbiota transplantation. Functionally, 16S rRNA sequencing, untargeted metabolomics, and co-incubation experiments revealed that the antifibrotic efficacy of HB was primarily contingent on the enrichment of Muribaculum intestinale and its metabolite, 3-hydroxybutyric acid. Mechanistically, indoleamine 2,3- dioxygenase 1 (IDO1)-mediated ferroptosis was identified as a pivotal process in initiating PF, and the anti-fibrotic efficacy of HB relies on suppressing IDO1-mediated ferroptosis. Conversely, IDO1 deficiency alleviated the symptoms of bleomycin-induced PF and ferroptosis in mice. Coincidentally, both IDO1 overexpression and ferroptosis were observed in the pulmonary tissue of patients with idiopathic PF. Collectively, this study revealed that HB alleviates PF by eliminating intestinal microecology and metabolism and highlights the feasibility of targeting IDO1 for PF treatment.http://www.sciencedirect.com/science/article/pii/S104366182500012XPulmonary fibrosisHeterophyllin BGut-lung axisIDO1FerroptosisMetabolism
spellingShingle Ce Chen
Jialin Wang
Mengqin Cheng
Haifeng Xie
Wei Li
Chaofeng Zhang
Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
Pharmacological Research
Pulmonary fibrosis
Heterophyllin B
Gut-lung axis
IDO1
Ferroptosis
Metabolism
title Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
title_full Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
title_fullStr Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
title_full_unstemmed Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
title_short Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
title_sort muribaculum intestinale derived 3 hydroxybutyric acid from heterophyllin b attenuated pulmonary fibrosis through ido1 mediated ferroptosis
topic Pulmonary fibrosis
Heterophyllin B
Gut-lung axis
IDO1
Ferroptosis
Metabolism
url http://www.sciencedirect.com/science/article/pii/S104366182500012X
work_keys_str_mv AT cechen muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis
AT jialinwang muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis
AT mengqincheng muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis
AT haifengxie muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis
AT weili muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis
AT chaofengzhang muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis